Latest filing published 26 Dec 2024 for NKGen Biotech, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Graf Acquisition Partners IV LLC: trading record in brief
This profile gathers the share dealings of Graf Acquisition Partners IV LLC in NKGen Biotech, Inc. Over a trading history stretching from 2 June 2021 to 20 December 2024, the count stands at 7 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 26 December 2024 came the latest disclosure, a transaction in NKGen Biotech, Inc. The median gap between a trade and its publication by SEC (Form 4) is 6 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Graf Acquisition Partners IV LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 63,634 shares0Common StockSEC:0001213900-24-112773:0
- 97,232 shares0Common StockSEC:0001213900-24-111880:0
- 1,773,631 shares0Common StockSEC:0001104659-23-106578:0
- 20,000 shares0Common StockSEC:0001104659-21-092153:0
- 22,125 shares0Common StockSEC:0001104659-21-075828:0
5 of 5 declarations